EADV 2025: Galderma Reinforces Leadership in Dermatology With Latest Advances in Sensitive Skin and Itch>

(BUSINESS WIRE)--Galderma (SIX: GALD), the dermatology category leader, today announced it will unveil updates from its portfolio at the 34th European Academy of Dermatology and Venereology (EADV) congress, taking place in Paris, September 17-20, 2025. Highlighting its commitment to addressing skin conditions across the dermatology spectrum, Galderma will present 12 abstracts, including data on sensitive skin, prurigo nodularis, and atopic dermatitis, and host a variety of events – from industry hubs on sensitive skin and acne, to a symposium on itch. Unveiling the global landscape of sensitive skin Galderma will present data from its robust research into sensitive skin, a growing global issue which now affects up to 70% of people worldwide – a 68% increase over the last 20 years.6,7 Data from a first-of-its-kind real-world clinical study conducted in China by Galderma’s Global Sensitive Skin Faculty (GSSF) – a global network of dermatology experts dedicated to advancing sensitive skin research and education – will be presented, revealing the biological impact of modern living and associated environmental factors on individuals with sen...(BUSINESS WIRE)--Galderma (SIX: GALD), the dermatology category leader, today announced it will unveil updates from its portfolio at the 34th European Academy of Dermatology and Venereology (EADV) congress, taking place in Paris, September 17-20, 2025. Highlighting its commitment to addressing skin conditions across the dermatology spectrum, Galderma will present 12 abstracts, including data on sensitive skin, prurigo nodularis, and atopic dermatitis, and host a variety of events – from industry hubs on sensitive skin and acne, to a symposium on itch. Unveiling the global landscape of sensitive skin Galderma will present data from its robust research into sensitive skin, a growing global issue which now affects up to 70% of people worldwide – a 68% increase over the last 20 years.6,7 Data from a first-of-its-kind real-world clinical study conducted in China by Galderma’s Global Sensitive Skin Faculty (GSSF) – a global network of dermatology experts dedicated to advancing sensitive skin research and education – will be presented, revealing the biological impact of modern living and associated environmental factors on individuals with sen...{}